Global Stable Isotope Labeled Biomolecules Market Insights, Forecast to 2025
An important tool for high-resolution structure determination for NMR spectroscopy is the use of stable isotopically labeled biomolecules. By either selectively or uniformly incorporating stable isotopes into proteins, the user is able to significantly reduce the complexity of their spectra. D Labeled Biomolecules, 15N, and deuterium are the most common isotopes incorporated into proteins. Microbial expression systems, cell-free extracts, peptide synthesis and custom synthesis provide a variety of options for accomplishing the incorporation of the labels. Microbial expression systems are cell-based protein expression systems in which the microbes are grown in either a defined or complex media with D Labeled Biomolecules labeled glucoses and 15N Labeled Biomoleculeslabeled ammonium salts as the sole sources of carbon and nitrogen respectively. Ease of use, adaptability and high protein yields have made these expression systems the most popular technique for stable isotope incorporation. Cell-free extracts and custom synthesis also present their own individual advantages with the use of uniformly or selectively labeled amino acids. Cell-free extracts allow the user to more readily implement high-throughput in vitro protein expression as many proteins are difficult to express in vivo due to complications such as toxicity. Custom synthesis allows for unique, site-specific incorporation of isotopes into peptides allowing the user to study distinct structural regions.
North America is the largest consumer by regions. North America accounted about 52.63% consumption market share in 2016. Europe is the second largest with 33.92% market share. China is the following consumption region with 5.53% consumption market share.
Scientific research, medical and industrial use is the main application of stable isotope labeled biomolecules. The three applications take nearly 88% of global stable isotope labeled biomolecules consumption in 2016.
The global Stable Isotope Labeled Biomolecules market is valued at 100 million US$ in 2018 and will reach 130 million US$ by the end of 2025, growing at a CAGR of 2.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Stable Isotope Labeled Biomolecules market based on company, product type, end user and key regions.
This report studies the global market size of Stable Isotope Labeled Biomolecules in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Stable Isotope Labeled Biomolecules in these regions.
This research report categorizes the global Stable Isotope Labeled Biomolecules market by top players/brands, region, type and end user. This report also studies the global Stable Isotope Labeled Biomolecules market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Cambridge Isotope Laboratories
Thermo Fisher Scientific
Toronto Research Chemicals
Market size by Product
D Labeled Biomolecules
15N Labeled Biomolecules
13C Labeled Biomolecules
Market size by End User
Market size by Region
Central & South America
Rest of Central & South America
Middle East & Africa
The study objectives of this report are:
To study and analyze the global Stable Isotope Labeled Biomolecules market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Stable Isotope Labeled Biomolecules market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Stable Isotope Labeled Biomolecules companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Stable Isotope Labeled Biomolecules submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Stable Isotope Labeled Biomolecules are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (g). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Stable Isotope Labeled Biomolecules market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.